| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/29/2004 | WO2004015107A3 Further novel forms of interfering rna molecules |
| 04/29/2004 | WO2004014311A3 Nogo receptor antagonists |
| 04/29/2004 | WO2004005534A3 Screening for alzheimer's disease |
| 04/29/2004 | WO2003104392A9 Improved reagents and methods for producing parvoviruses |
| 04/29/2004 | WO2003089622A3 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 04/29/2004 | WO2003087368A3 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 04/29/2004 | WO2003087367A3 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | US20040082775 Dissolving of raw materials; solvent extraction |
| 04/29/2004 | US20040082774 Novel phosphate and thiophosphate protecting groups |
| 04/29/2004 | US20040082766 Carrier having surface overcoated with noble metal; supplying sample; binding |
| 04/29/2004 | US20040082761 Cell adhesion proteins |
| 04/29/2004 | US20040082532 Antifungal therapeutic targets |
| 04/29/2004 | US20040082508 For diagnosis/treatment/prevention of cell proliferative/ autoimmune/inflammatory/cardiovascular/neurological diseases |
| 04/29/2004 | US20040082048 Mixture containing enzyme; malaria therapy |
| 04/29/2004 | US20040082037 Antiproliferative agents of vascular smooth muscles |
| 04/29/2004 | US20040082029 Autoimmune diseases; antiinflammatory agents; transgenic organism; binding to antibodies |
| 04/29/2004 | US20040082028 Genetic engineering; three-dimensional construction; heat resistance; used for converting starch to sugar |
| 04/29/2004 | US20040081999 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 04/29/2004 | US20040081995 Dna polymerase; genetic engineering |
| 04/29/2004 | US20040081988 Splice variant isoforms of human calcium channel CACNA1B |
| 04/29/2004 | US20040081983 Kinases and phosphatases |
| 04/29/2004 | US20040081980 Polynucleotides; genetic engineering; diagnosis, therapy, prevent disease; detect binding to antibody |
| 04/29/2004 | US20040081976 Genomic screen for epigenetically silenced tumor suppressor genes |
| 04/29/2004 | US20040081970 Isolated nucleic acids; antibody for selective binding |
| 04/29/2004 | US20040081965 Mutants; genetic engineering; amplification |
| 04/29/2004 | US20040081964 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 04/29/2004 | US20040081963 Joining polymerase to nucleic acids |
| 04/29/2004 | US20040081961 Genetic engineering; therapy, diagnosis of disease; gastrointestinal, cardiovascular diseases; autoimmune disease; antiinflammatory agents; central nervous system disorders; antitumor, anticancer agents |
| 04/29/2004 | US20040081959 Using oligonucleotide detectors; hybridization analyzing |
| 04/29/2004 | US20040081958 Identification and use of molecular markers indicating cellular reprogramming |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081646 Group B Streptococcal phage lysin |
| 04/29/2004 | DE10328887A1 Alkalische Protease Alkaline protease |
| 04/29/2004 | CA2649821A1 Polynucleotide sequences encoding .delta.bcl-2 for preventing and treating autoimmune diseases |
| 04/29/2004 | CA2501946A1 Compositions and methods for detecting west nile virus |
| 04/28/2004 | EP1413352A1 Linking to chemical array assemblies with metal layers |
| 04/28/2004 | EP1412522A1 Amplifiable probe |
| 04/28/2004 | EP1412518A2 Sorting and immobilization system for nucleic acids using synthetic binding systems |
| 04/28/2004 | EP1412505A2 Dna sequences for regulating transcription |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1412413A1 Synthesis and use of organosilica particles |
| 04/28/2004 | EP1412376A2 Compositions and methods for labeling oligonucleotides |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411765A1 Enhancement of the stability of oligonucleotides comprising phosphorothioate linkages by addition of water-soluble antioxidants |
| 04/28/2004 | EP1159064B1 Method for photolytically deprotecting immobilized nucleoside derivatives, especially in the production of dna chips |
| 04/28/2004 | EP1017703B1 Pentopyranosyl nucleoside, and production and use of the same |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0777498B1 Conjugates made of metal complexes and oligonucleotides |
| 04/28/2004 | EP0698095B1 Bmp-10 compositions |
| 04/28/2004 | CN1492055A Determination of a section of mycoplasma urealyticum DNA sequence (4) specificity and its use |
| 04/28/2004 | CN1492054A Determination of man-shaped mycoplasma DNA sequence (2) specificity and its use |
| 04/28/2004 | CN1492053A Determination of man-shaped mycoplasma DNA sequence (5) specificity and its use |
| 04/28/2004 | CN1492052A Determination of a section of man-shaped mycoplasma DNA sequence (4) specificity and its use |
| 04/28/2004 | CN1491956A Gene for changing cotton fiber quantity and character and its encoding protein and use |
| 04/28/2004 | CN1491955A Method for extracting bacteria mRNA |
| 04/28/2004 | CN1491954A High efficiency quick degradation genome DNA of light sensitive aromatic heterocyclic compound |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147502C Method for large-scale production of Di (uridine 5'-tetraphosphate) and salts thereof |
| 04/27/2004 | US6727356 Fluorescent quenching detection reagents and methods |
| 04/27/2004 | US6727080 Monoclonal antibodies for use in cancer immunotherapy and their preparation; marker not restricted to previously defined histological classes of cancer |
| 04/27/2004 | US6727077 Used for detecting and treating cancer |
| 04/27/2004 | US6727064 Antiinflammatory agents; anticarcinogenic agents |
| 04/27/2004 | US6727061 Methods for identifying species or Shigella and E. coli using operon sequence analysis |
| 04/27/2004 | US6726880 Device comprising support substrate, array of microlocations comprising electronically addressable electrodes, two collection electrodes adjacent to opposite sides of array, and flow cell adapted to be supported on substrate |
| 04/27/2004 | US6726847 Silver stain removal by chemical etching and sonication |
| 04/27/2004 | CA2177732C Antisense oligonucleotides having tumorigenicity-inhibiting activity |
| 04/27/2004 | CA2152047C Production of human recombinant collagen in the milk of transgenic animals |
| 04/22/2004 | WO2004033719A1 In situ nucleic acid chip and the preparation method thereof |
| 04/22/2004 | WO2004033640A2 A transgenic animal comprising a gene operably linked to a cell cycle activated promoter |
| 04/22/2004 | WO2004033636A2 Protein modification and maintenance molecules |
| 04/22/2004 | WO2004033486A2 Production of homotrimeric fusion proteins |
| 04/22/2004 | WO2004033485A2 Nucleic acid supported protein complementation |
| 04/22/2004 | WO2004033477A1 Modified nucleotide sequence encoding c. albicans krp kinesin protein |
| 04/22/2004 | WO2004033471A2 Glucose transport mutants for production of biomaterial |
| 04/22/2004 | WO2004032877A2 Compositions, organisms and methodologies employing a novel human kinase |
| 04/22/2004 | WO2004032860A2 Hiv vaccine formulations |
| 04/22/2004 | WO2004032839A2 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/22/2004 | WO2004032599A2 Novel immunogenic proteins of leptospira |
| 04/22/2004 | WO2004016349A3 Method and device for the intermolecular transport of bond cleavage activation energy through space |
| 04/22/2004 | WO2004015395A3 Method for identifying mhc-presented peptide epitopes for t cells |
| 04/22/2004 | WO2003070965A8 The eaat2 promoter and uses thereof |
| 04/22/2004 | WO2003068798A3 Oligonucleotide analogues and methods of use for modulating gene expression |
| 04/22/2004 | WO2003064625A3 Oligonucleotide compositions with enhanced efficiency |
| 04/22/2004 | WO2003060084A9 Methods for making polynucleotides and purifying double-stranded polynucleotides |
| 04/22/2004 | WO2003051272A9 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR GnRH-I AND GnRH-II MODULATION OF T-CELL ACTIVITY, ADHESION, MIGRATION AND EXTRAVASATION |
| 04/22/2004 | WO2003040400A8 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids |
| 04/22/2004 | WO2003039346A8 Diagnostics and therapeutics for ocular abnormalities |
| 04/22/2004 | WO2003020893A3 New adenovirus type 7 vectors |
| 04/22/2004 | WO2002092784A3 POLYNUCLEOTIDES AND POLYPEPTIDES RELATING TO THE MODULATION OF SIRP α-CD47 |
| 04/22/2004 | US20040078852 DNA encoding a binding protein of an ap2 domain amino acid sequence; enhancing the drought and cold tolerance of recombinant plants |
| 04/22/2004 | US20040078846 Carotenoid biosynthesis |
| 04/22/2004 | US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene |
| 04/22/2004 | US20040077833 Regulation of human mrp5-like protein |
| 04/22/2004 | US20040077832 Jfy1protein induces rapid apoptosis |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077585 Using P2Y receptor agonists with enhanced resistance to extracellular hydrolysis; such as dinucleoside polyphosphate compounds |
| 04/22/2004 | US20040077570 Decreasing adiposity, leptin, cholesterol, lipid and glucose levels |
| 04/22/2004 | US20040077569 Hybridizes with and inhibits expression of nucleic acid molecule encoding alternatively spliced or truncated form; hyperproliferative disorders |
| 04/22/2004 | US20040077568 Inhibitors; oligonucleotides specifically hybridizable with encoding nucleic acids |